Effect of zinc on gene expression in osteoblastic MC3T3-E1 cells: Enhancement of Runx2, OPG, and regucalcin mRNA expressions

Molecular and Cellular Biochemistry

Volumn 312, Issue 1-2, 2008, Pages 157-166

  Yamaguchi, Masayoshi ^a,b   Goto, Maya ^a   Uchiyama, Satoshi ^a   Nakagawa, Taeko ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b Institute of Bone Health and Nutrient   (Japan)

Author keywords

Bone formation; OPG; Osteoblast; Regucalcin; Runx2; Zinc

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; ACEXAMATE ZINC; COLLAGEN; COLLAGEN ALPHA1 CHAIN; CYCLOHEXIMIDE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN; POLAPREZINC; REGUCALCIN; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; ZINC SULFATE; ZINC TRANSPORTER; ZINC TRANSPORTER 1;

ANIMAL CELL; ARTICLE; CELL COUNT; CONTROLLED STUDY; CULTURE MEDIUM; GENE CONTROL; GENE EXPRESSION; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; CYCLOHEXIMIDE; DICHLORORIBOFURANOSYLBENZIMIDAZOLE; GENE EXPRESSION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OSTEOBLASTS; OSTEOPROTEGERIN; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; UP-REGULATION; ZINC; ZINC COMPOUNDS;

BOVINAE;

EID: 42149096706     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-008-9731-7     Document Type: Article

References (45)

1. Prasad AS, Halsted JA, Nadimi M (1961) Syndrome of iron deficiency anemia, hepatosplenomegaly, hypoganadism, dwarfism and geophagia. Am J Med 31:532-546
2. Burt RE, Khan HK, Sullivan JF (1975) Newer aspects of the roles of zinc, manganese, and copper in human nutrition. Clin Chem 21:501-520
3. Hsieh HS, Navia JM (1980) Zinc deficiency and bone formation in guinea pig alveolar implants. J Nutr 110:1582-1588
4. Oner G, Bhaumick B, Bala RM (1984) Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 114:1860-1863
5. Yamaguchi M, Ozaki K (1990) Aging affects cellular zinc and protein synthesis in the femoral diaphysis of rats. Res Exp Med 190:295-300
6. Yamaguchi M, Ehara Y (1995) Zinc decrease and bone metabolism in femoral-metaphyseal tissues of rats with skeletal unloading. Calcif Tissue Int 57:218-223
7. Reginster JY, Strause LG, Saltman P, Franchimont P (1998) Trace elements and postmenopausal osteoporosis. A preliminary study of decreased serum manganese. Med Sci Res 16:337-338
8. Herzberg M, Foldes J, Steinberg R, Menczel J (1990) Zinc excretion in osteoporotic woman. J Bone Miner Res 5:251-257
9. Kishi S, Segawa Y, Yamaguchi M (1994) Histomorphological confirmation of the preventive effect of β-alanyl-l-histidinato zinc on bone loss in ovariectomized rats. Biol Pharm Bull 17:862-865
10. Higashi A, Nakamura T, Nishiyama S, Matsukura M, Tomoeda S, Futagoshi Y, Shinohara M, Matsuda I (1993) Zinc kinetics in patients with bone demineralization due to physical immobilization. J Am Coll Nutr 12:61-65
11. Yamaguchi M (1998) Role of zinc in bone formation and bone resorption. J Trace Elem Exp Med 11:119-135
12. Yamaguchi M, Uchiyama S (2003) Preventive effect of zinc acexamate administration in streptozotocin-diabetic rats: Restoration of bone loss. Int J Mol Med 12:755-761
13. Yamaguchi M, Oishi H, Suketa Y (1987) Stimulatory effect of zinc on bone formation in tissue culture. Biochem Pharmacol 36:4007-4012
14. Yamaguchi M, Hashizume M (1994) Effect of β-alanyl-l-histidinato zinc on protein components in osteoblastic MC3T3-E1 cells: Increase in osteocalcin, insulin-like growth factor-land transforming growth factor-β. Mol Cell Biochem 136:163-169
15. Lutz W, Burritt MF, Nixon DE, Kao PC, Kumar R (2000) Zinc increases the activity of vitamin D-dependent promoters in osteoblasts. Biochem Biophys Res Commun 271:1-7
16. Yamaguchi M, Segawa Y, Shimokawa N, Tsuzuike N, Tagashira E (1992) Inhibitory effect of β-alanyl-l-histidinato zinc on bone resorption in tissue culture. Pharmacology 45:292-300
17. Kishi S, Yamaguchi M (1994) Inhibitory effect of zinc compounds on osteoclast-like cell formation in mouse marrow cultures. Biochem Pharmacol 48:1225-1230
18. Holloway WR, Collier FM, Herbst RE, Modge JM, Nicholson GC (1996) Osteoblast-mediated effects of zinc on isolated rat osteoclast: inhibition of bone resorption and enhancement of osteoclast number. Bone 19:137-142
19. Yamaguchi M, Ohtaki J (1991) Effect of beta-alanyl-l-histidinato zinc on osteoblastic MC3T3-E1 cells: Increase in alkaline phosphatase and proliferation. Pharmacology 43:225-232
20. Yamaguchi M, Fukagawa M (2005) Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: Zinc modulation of insulin-like growth factor-1's effect. Calcif Tissue Int 76:32-38
21. Yamaguchi M, Kishi S, Hashizume M (1994) Effect of zinc-chelating dipeptides on osteoblastic MC3T3-E1 cells: Activation of aminoacyl-tRNA synthetase. Peptides 15:1367-1371
22. Yamaguchi M, Matsui T (1996) Stimulatory effect of zinc-chelating dipeptides on deoxyribonucleic acid synthesis in osteoblastic MC3T3-E1 cells. Peptides 17:1207-1211
23. Yamaguchi M, Kishi S (1996) Zinc compounds inhibit osteoclast-like cell formation at the earlier stage of rat marrow culture but not osteoclast formation. Mol Cell Biochem 158:171-177
24. Zaidi M, Blair HC, Moonga BS, Abe E, Huang CL-H (2003) Osteoclastogenesis, bone resorption, and osteoclast-based therapeutics. J Bone Miner Res 18:599-609
25. Yamaguchi M, Uchiyama S (2004) Receptor activator of NF-κB ligand-stimulated osteoclastogenesis in mouse marrow culture is suppressed by zinc in vitro. Int J Mol Med 14:81-85
26. Hashizume M, Yamaguchi M (1993) Stimulatory effect of β-alanyl- l -histidinato zinc on cell proliferation is dependent on protein synthesis in osteoblastic MC3T3-E1 cells. Mol Cell Biochem 122:59-64
27. Hashizume M, Yamaguchi M (1994) Effect of β-alanyl-l-histidinate zinc on differentiation of osteoblastic MC3T3-E1 cells: Increases in alkaline phosphatase activity and protein concentration. Mol Cell Biochem 131:19-24
28. Yamaguchi M, Oishi H, Suketa Y (1988) Zinc stimulation of bone protein synthesis in tissue culture. Activation of aminoacyl-tRNA synthetase. Biochem Pharmacol 37:4075-4080
29. Chomczyshi P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159
30. Sohn KY, Maity SN, de Crombrugghe B (1994) Studies on the structure of CBF-A isoform generated from an alternatively spliced RNA. Gene 139:147-153
31. Desbois C, Hogue DA, Karsenty G (1994) The mouse osteocalcin gene culture contains three genes with two separate spatial and temporal patterns of expression. J Biol Chem 269:1183-1190
32. Luppen CA, Smith E, Spevak L, Boskey AL, Frenkel B (2003) Bone morphogenetic protein-2 restores mineralization in glucocorticoid-inhibited MC3T3-E1 osteoblast cultures. J Bone Miner Res 18:1186-1197
33. Bell GI, Stempien MM, Fong NW, Roll LB (1986) Sequences of liver cDNAs encoding two different mouse insulin-like growth factor I precursors. Nucleic Acids Res 14:7873-7882
34. Deryck R, Jarrett JA, Chen EY, Goeddel DV (1986) The murine transforming growth factor-beta precursor. J Biol Chem 261:4377-4379
35. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee R, Boyle WJ (1997) Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319
36. Lioumi M, Ferguson CA, Sharpe PT, Freeman T, Marenholz I, Mischke D, Heizmann C, Ragoussis J (1999) Isolation and characterization of human and mouse ZIRTL, a member of the IRT1 family of transporters, mapping within the epidermal differentiation complex. Genomics 62:272-8037
37. 2+-binding protein regucalcin is highly conserved in vertebrate species. Int J Mol Med 6:191-196
38. Komori T, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764
39. Tanaka S, Nakajima I, Inoue J-I, Oda H, Nakamura K (2003) Signal transduction pathways regulating osteoclast differentiation and function. J Biol Miner Metab 21:123-133
40. Yamaguchi M (2005) Role of regucalcin in maintaining cell homeostasis and function. Int J Mol Med 15:372-389
41. Yamaguchi M, Kobayashi M, Uchiyama S (2005) Suppressive effect of regucalcin on cell differentiation and mineralization in osteoblastic MC3T3-E1 cells. J Cell Biochem 96:543-554
42. Yamaguchi M, Uchiyama S (2005) Regucalcin stimulates osteoclast-like cell formation in mouse marrow cultures. J Cell Biochem 94:794-803
43. Yamaguchi M, Misawa H, Uchiyama S, Morooka Y, Tsurusaki Y (2002) Role of endogenous regucalcin in bone metabolism: Bone loss is induced in regucalcin transgenic rats. Int J Mol Med 10:377-383
44. Yamaguchi M, Kishi S (1994) Effect of zinc-chelating dipeptides on bone metabolism in weanling rats: Comparison with β-alanyl-L -histidinato zinc-related compounds. Peptides 15:671-673
45. Yamaguchi M, Gao YH (1998) Potent effect of zinc acexamate on bone components in the femoral-metaphyseal tissues of elderly female rats. Gen Pharmacol 30:423-427